Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer

Published:2018 Issue:6 Volume:9 Page:941-949
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Misawa Kiyoshi,Misawa Yuki,Imai Atsushi,Mochizuki Daiki,Endo Shiori,Mima Masato,Ishikawa Ryuji,Kawasaki Hideya,Yamatodani Takashi,Kanazawa Takeharu

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review;Frontiers in Oncology;2024-07-26

2. Epigenetic regulation of head and neck cancer by microRNAs;Diagnostic, Prognostic, and Therapeutic Role of MicroRNAs in Head and Neck Cancer;2024

3. SALL1 promotes proliferation and metastasis and activates phosphorylation of p65 and JUN in colorectal cancer cells;Pathology - Research and Practice;2023-10

4. Analysis of the value of dynamic computed tomography (CT) examination in the diagnosis of early lung cancer.;Investigación Clínica;2023-06-01

5. Accurate prediction of pan-cancer types using machine learning with minimal number of DNA methylation sites;Journal of Molecular Cell Biology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP